Scrip Regulatory Affairs
US FDA explains info needed for formal product classification requests
21 April 2011
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA may be calling for increasingly demanding device study designs, signals draft guidance
- SMEs contacted US FDA's drug ombudsman more often than big pharma in 2011
- Malaysia consults on grouping of devices to facilitate registration process
- Proposed new feature in future EU IVD Regulation: the classification rules
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
